Court of Appeals Upholds FDA Award of Gabapentin Exclusivity to Alpharma
The U.S. District Appeals Court for the District of Columbia rejected a challenge from generic drug maker Apotex and upheld rival Alpharma's 180-day marketing exclusivity period for gabapentin capsules....To view the full article, register now.
Already a subscriber? Click here to view full article